Published in Transplantation on January 15, 2001
Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol (2010) 0.90
Acute antibody-mediated rejection in paediatric renal transplant recipients. Pediatr Nephrol (2011) 0.84
Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation. Trans Am Clin Climatol Assoc (2006) 0.81
Intravenous immunoglobulin as clinical immune-modulating therapy. CMAJ (2015) 0.81
Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells. Clin Exp Immunol (2013) 0.81
Late and chronic antibody-mediated rejection: main barrier to long term graft survival. Clin Dev Immunol (2013) 0.79
Acute Antibody-Mediated Rejection in Renal Transplantation: Current Clinical Management. Curr Transplant Rep (2014) 0.76
Clinical applications of immunoglobulin: update. Rev Bras Hematol Hemoter (2011) 0.75
Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step. J Immunol Res (2017) 0.75
Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation. Medicine (Baltimore) (2016) 0.75
Intravenous immunoglobulin for antibody-mediated keratolimbal allograft rejection. BMJ Case Rep (2015) 0.75
Immunoglobulin G promotes skin graft acceptance in an immunologically potent rat model. Oncotarget (2016) 0.75
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Effect of the orientation of donor and acceptor on the probability of energy transfer involving electronic transitions of mixed polarization. Biochemistry (1978) 2.68
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Distribution of end-to-end distances of oligopeptides in solution as estimated by energy transfer. Proc Natl Acad Sci U S A (1975) 2.50
Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet (1995) 2.50
Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16
Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant (2013) 2.12
Bacterial colonization of the respiratory tract following tracheal intubation-effect of gravity: an experimental study. Crit Care Med (2003) 2.11
Evaluation of the distribution of distances between energy donors and acceptors by fluorescence decay. Proc Natl Acad Sci U S A (1972) 1.97
[Immunological aspects of kidney transplantation in Switzerland 1981-1992. Swiss Transplant Work Group Kidney Transplantation]. Schweiz Med Wochenschr (1995) 1.91
Closed system endotracheal suctioning maintains lung volume during volume-controlled mechanical ventilation. Intensive Care Med (2001) 1.77
Incidence and predictors of acute symptomatic seizures after stroke. Neurology (2011) 1.68
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem (2001) 1.57
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med (1995) 1.56
TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol (1999) 1.52
Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health (1995) 1.52
Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production. Dig Dis Sci (1996) 1.47
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
The sex-inducing pheromone and wounding trigger the same set of genes in the multicellular green alga Volvox. Plant Cell (1998) 1.44
Intramolecular dynamics of chain molecules monitored by fluctuations in efficiency of excitation energy transfer. A theoretical study. Biophys J (1984) 1.44
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Evaluation of HLA matching for CREG antigens in Europe. Transplantation (1999) 1.43
Simultaneous determination of intramolecular distance distributions and conformational dynamics by global analysis of energy transfer measurements. Biophys J (1989) 1.43
DNA ploidy pattern in choroidal melanoma: correlation with survival. A flow cytometry study on archival material. Br J Ophthalmol (1998) 1.43
Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant (2009) 1.43
HLA DNA typing and transplantation. Immunity (2001) 1.42
Extraction, purification, and assay of human renin free of angiotensinase. Circ Res (1966) 1.42
Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40
Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study. Minerva Anestesiol (2013) 1.39
Lymphocyte abnormalities in ankylosing spondylitis. Ann Rheum Dis (1977) 1.39
IL-6 independent monocyte/B cell defect in renal transplant recipients with long-term stable graft function. Transplantation (1994) 1.39
Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J Biol Chem (2000) 1.33
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
A sensitive fluorometric assay for alpha-chymotrypsin. Anal Biochem (1971) 1.32
CYTOCHROME B2. Science (1942) 1.32
Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32
Domain closure in adenylate kinase. Biochemistry (1996) 1.31
A general strategy for site-specific double labeling of globular proteins for kinetic FRET studies. Bioconjug Chem (2002) 1.30
Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. J Clin Invest (1998) 1.30
Defective T cell function in atopic dermatitis. J Allergy Clin Immunol (1976) 1.26
Domain motions in phosphoglycerate kinase: determination of interdomain distance distributions by site-specific labeling and time-resolved fluorescence energy transfer. Proc Natl Acad Sci U S A (1992) 1.25
Improved kidney graft survival in nontransfused recipients. Transplant Proc (1987) 1.22
Distributions of intramolecular distances in the reduced and denatured states of bovine pancreatic ribonuclease A. Folding initiation structures in the C-terminal portions of the reduced protein. Biochemistry (2001) 1.20
A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. Blood (2001) 1.19
HLA class I DNA typing of 215 "HLA-A, -B, -DR zero mismatched" kidney transplants. Tissue Antigens (1997) 1.19
Characterization of functionally distinct lymphoid and myeloid cells from human blood and bone marrow. I. Separation by a buoyant density gradient technique. J Immunol Methods (1977) 1.19
Induction of high kidney graft survival rate by multiple transfusion. Lancet (1981) 1.18
TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J Biol Chem (1998) 1.17
Identification of unresponsive kidney-transplant recipients. Lancet (1972) 1.16
Analysis of the structure of ribonuclease A in native and partially denatured states by time-resolved noradiative dynamic excitation energy transfer between site-specific extrinsic probes. Biochemistry (1995) 1.15
Multiple sclerosis and high incidence of a B lymphocyte antigen. Science (1976) 1.14
Effect of splenectomy on human renal transplants. Transplantation (1973) 1.12
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol (2011) 1.11
QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis. Gene Ther (2009) 1.11
Determination of intramolecular distance distribution during protein folding on the millisecond timescale. J Mol Biol (2000) 1.11
Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc (1977) 1.10
Methicillin-resistant Staphylococcus aureus (MRSA) in foods of animal origin product in Italy. Int J Food Microbiol (2007) 1.08
Dominant effect of transfusions on kidney graft survival. Transplantation (1980) 1.07
Autoimmune panleukopenia. N Engl J Med (1976) 1.07
Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma. Transplant Proc (1973) 1.07
Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma). Tissue Antigens (1978) 1.07
Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest (1997) 1.07
Prediction of long-term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation (1978) 1.06
Human renal renin. Complete purification and characterization. J Biol Chem (1980) 1.06
Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies. Environ Health Perspect (2001) 1.06
Evaluation of Belzer and Collins kidney-preservation methods. Lancet (1973) 1.06
Development of a nested PCR assay for the detection of canine coronavirus. J Virol Methods (1999) 1.05
Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis. J Infect Dis (1975) 1.04
The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody. Proc Natl Acad Sci U S A (1997) 1.04
Combined minimal invasive techniques in deep supratentorial intracerebral haematomas. Minim Invasive Neurosurg (2004) 1.03
Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation (1985) 1.03
Comparison of kidney transplant survival among transplant centers. Transplantation (1975) 1.03
HL-A and kidney transplants: reexamination. Transplantation (1974) 1.03
Second kidney transplants and presensitization. Transplant Proc (1972) 1.03
Enhancement of kidney graft survival by blood transfusions. Transplant Proc (1977) 1.03
Nonlocal interactions stabilize compact folding intermediates in reduced unfolded bovine pancreatic trypsin inhibitor. Biochemistry (1992) 1.03
Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin Cancer Res (1997) 1.02
The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. Int Immunopharmacol (2001) 1.02
Effect of blood-group on relation between HLA match and outcome of cadaver kidney transplants. Lancet (1977) 1.01
Conformational studies of a peptide corresponding to a region of the C-terminus of ribonuclease A: implications as a potential chain-folding initiation site. Biochemistry (1991) 1.00
Superfibronectin, a multimeric form of fibronectin, increases HIV infection of primary CD4+ T lymphocytes. J Immunol (2000) 0.99
Fast collapse but slow formation of secondary structure elements in the refolding transition of E. coli adenylate kinase. J Mol Biol (2005) 0.99
Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr Biol (1998) 0.99
Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients. Clin Exp Immunol (1989) 0.99
Commentary: does immune suppression increase risk of developing acute myeloid leukemia? Leukemia (2011) 0.98
Antigenic analysis of canine parvovirus strains isolated in Italy. New Microbiol (2000) 0.98
Absence of immunization effect in human-kidney retransplantation. N Engl J Med (1978) 0.98
Detection of local structures in reduced unfolded bovine pancreatic trypsin inhibitor. Proteins (1992) 0.97
Influence of sex on histocompatibility matching in renal transplantation. Lancet (1977) 0.97
Thymus-dependent lymphocytes in human bone marrow. J Clin Invest (1975) 0.96
Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor. J Med Chem (1996) 0.96
Isolation of Salmonella strains from reptile faeces and comparison of different culture media. J Appl Microbiol (2004) 0.96
FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. Ann Hematol (2003) 0.96
Prolongation effect of blood transfusions on kidney graft survival. Transplantation (1976) 0.95
In vitro and clinical studies of cefatrizine, a new semisynthetic cephalosporin. Antimicrob Agents Chemother (1976) 0.95
Association of elevated blood levels of pentachlorophenol (PCP) with cellular and humoral immunodeficiencies. Arch Environ Health (2001) 0.95